SHA:600329 Market Cap

SHA:600329 has a market cap or net worth of 27.87 billion as of March 9, 2026. Its market cap has increased by 29.02% in one year.

Market Cap

27.87B

Enterprise Value

26.17B

Revenue

5.37B

Ranking

n/a

PE Ratio

8.84

Stock Price

41.15

Market Cap Chart

Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 27.87B, an increase of 302.96%. That is a compound annual growth rate of 5.79%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	27.87B	-9.46%
Dec 31, 2025	30.78B	48.69%
Dec 31, 2024	20.70B	-6.43%
Dec 29, 2023	22.12B	21.24%
Dec 30, 2022	18.25B	-6.30%
Dec 31, 2021	19.47B	73.88%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shijiazhuang Yiling Pharmaceutical	28.00B
Livzon Pharmaceutical Group	27.97B
Kangmei Pharmaceutical	26.00B
Chengdu Kanghong Pharmaceutical Group	25.74B
Hubei Jumpcan Pharmaceutical	25.57B
Humanwell Healthcare (Group)	32.17B
Dong-E-E-Jiao	33.79B
Zhejiang Huahai Pharmaceutical	23.83B

Market Cap Rankings